Patents by Inventor Nils Danielsen
Nils Danielsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10363411Abstract: A medical microelectrode includes an elongate electrode body including a tip section, a main body section and, optionally, a coupling section. The tip section, the main body section and, optionally, the coupling section are embedded in a first electrode matrix element, which is substantially rigid, biocompatible and soluble or biodegradable in a body fluid. Additionally the microelectrode includes a dissolution retarding layer on the first electrode matrix element and/or a second electrode matrix element disposed between the first electrode matrix element and the electrode. Upon dissolution or biodegradation of the first electrode matrix element a drug comprised by the first electrode matrix element or the second electrode matrix element is released into the tissue. Also disclosed are bundles and arrays of the electrodes and their use.Type: GrantFiled: June 13, 2017Date of Patent: July 30, 2019Assignee: NEURONANO ABInventors: Fredrik Ek, Nils Danielsen, Jenny Eriksson Linsmeier, Per Petersson, Jens Schouenborg
-
Patent number: 10188854Abstract: A medical microelectrode includes an elongate electrode body including a tip section, a main body section and, optionally, a coupling section. The tip section, the main body section and, optionally, the coupling section are embedded in a first electrode matrix element, which is substantially rigid, biocompatible and soluble or biodegradable in a body fluid. Additionally the microelectrode includes a dissolution retarding layer on the first electrode matrix element and/or a second electrode matrix element disposed between the first electrode matrix element and the electrode. Upon dissolution or biodegradation of the first electrode matrix element a drug comprised by the first electrode matrix element or the second electrode matrix element is released into the tissue. Also disclosed are bundles and arrays of the electrodes and their use, which may be positioned on a face of a solid support.Type: GrantFiled: December 8, 2016Date of Patent: January 29, 2019Assignee: NEURONANO ABInventors: Fredrik Ek, Nils Danielsen, Jenny Eriksson Linsmeier, Per Petersson, Jens Schouenborg
-
Patent number: 9878147Abstract: A medical microelectrode includes an elongate electrode body including a tip section, a main body section and, optionally, a coupling section. The tip section, the main body section and, optionally, the coupling section are embedded in a first electrode matrix element, which is substantially rigid, biocompatible and soluble or biodegradable in a body fluid. Additionally the microelectrode includes a dissolution retarding layer on the first electrode matrix element and/or a second electrode matrix element disposed between the first electrode matrix element and the electrode. Upon dissolution or biodegradation of the first electrode matrix element a drug comprised by the first electrode matrix element or the second electrode matrix element is released into the tissue. Also disclosed are bundles and arrays of the electrodes and their use.Type: GrantFiled: February 6, 2015Date of Patent: January 30, 2018Assignee: NEURONANO ABInventors: Fredrik Ek, Nils Danielsen, Jenny Eriksson Linsmeier, Per Petersson, Jens Schouenborg
-
Publication number: 20170274201Abstract: A medical microelectrode includes an elongate electrode body including a tip section, a main body section and, optionally, a coupling section. The tip section, the main body section and, optionally, the coupling section are embedded in a first electrode matrix element, which is substantially rigid, biocompatible and soluble or biodegradable in a body fluid. Additionally the microelectrode includes a dissolution retarding layer on the first electrode matrix element and/or a second electrode matrix element disposed between the first electrode matrix element and the electrode. Upon dissolution or biodegradation of the first electrode matrix element a drug comprised by the first electrode matrix element or the second electrode matrix element is released into the tissue. Also disclosed are bundles and arrays of the electrodes and their use.Type: ApplicationFiled: June 13, 2017Publication date: September 28, 2017Inventors: Fredrik EK, Nils DANIELSEN, Jenny ERIKSSON LINSMEIER, Per PETERSSON, Jens SCHOUENBORG
-
Publication number: 20170087352Abstract: A medical microelectrode includes an elongate electrode body including a tip section, a main body section and, optionally, a coupling section. The tip section, the main body section and, optionally, the coupling section are embedded in a first electrode matrix element, which is substantially rigid, biocompatible and soluble or biodegradable in a body fluid. Additionally the microelectrode includes a dissolution retarding layer on the first electrode matrix element and/or a second electrode matrix element disposed between the first electrode matrix element and the electrode. Upon dissolution or biodegradation of the first electrode matrix element a drug comprised by the first electrode matrix element or the second electrode matrix element is released into the tissue. Also disclosed are bundles and arrays of the electrodes and their use, which may be positioned on a face of a solid support.Type: ApplicationFiled: December 8, 2016Publication date: March 30, 2017Applicant: NEURONANO ABInventors: Fredrik EK, Nils DANIELSEN, Jenny ERIKSSON LINSMEIER, Per PETERSSON, Jens SCHOUENBORG
-
Patent number: 9533140Abstract: A medical microelectrode includes an elongate electrode body including a tip section, a main body section and, optionally, a coupling section. The tip section, the main body section and, optionally, the coupling section are embedded in a first electrode matrix element, which is substantially rigid, biocompatible and soluble or biodegradable in a body fluid. Additionally the microelectrode includes a dissolution retarding layer on the first electrode matrix element and/or a second electrode matrix element disposed between the first electrode matrix element and the electrode. Upon dissolution or biodegradation of the first electrode matrix element a drug comprised by the first electrode matrix element or the second electrode matrix element is released into the tissue. Also disclosed are bundles and arrays of the electrodes and their use.Type: GrantFiled: July 11, 2014Date of Patent: January 3, 2017Assignee: NEURONANO ABInventors: Fredrik Ek, Nils Danielsen, Jenny Eriksson Linsmeier, Per Petersson, Jens Schouenborg
-
Publication number: 20150151109Abstract: A medical microelectrode includes an elongate electrode body including a tip section, a main body section and, optionally, a coupling section. The tip section, the main body section and, optionally, the coupling section are embedded in a first electrode matrix element, which is substantially rigid, biocompatible and soluble or biodegradable in a body fluid. Additionally the microelectrode includes a dissolution retarding layer on the first electrode matrix element and/or a second electrode matrix element disposed between the first electrode matrix element and the electrode. Upon dissolution or biodegradation of the first electrode matrix element a drug comprised by the first electrode matrix element or the second electrode matrix element is released into the tissue. Also disclosed are bundles and arrays of the electrodes and their use.Type: ApplicationFiled: February 6, 2015Publication date: June 4, 2015Inventors: Fredrik Ek, Nils Danielsen, Jenny Eriksson Linsmeier, Per Petersson, Jens Schouenborg
-
Patent number: 8954142Abstract: A medical microelectrode includes an elongate electrode body including a tip section, a main body section and, optionally, a coupling section. The tip section, the main body section and, optionally, the coupling section are embedded in a first electrode matrix element, which is substantially rigid, biocompatible and soluble or biodegradable in a body fluid. Additionally the microelectrode includes a dissolution retarding layer on the first electrode matrix element and/or a second electrode matrix element disposed between the first electrode matrix element and the electrode. Upon dissolution or biodegradation of the first electrode matrix element a drug comprised by the first electrode matrix element or the second electrode matrix element is released into the tissue. Also disclosed are bundles and arrays of the electrodes and their use.Type: GrantFiled: June 3, 2010Date of Patent: February 10, 2015Assignee: Nauronano ABInventors: Fredrik Ek, Nils Danielsen, Jenny Eriksson Linsmeier, Per Petersson, Jens Schouenborg
-
Publication number: 20140323948Abstract: A medical microelectrode includes an elongate electrode body including a tip section, a main body section and, optionally, a coupling section. The tip section, the main body section and, optionally, the coupling section are embedded in a first electrode matrix element, which is substantially rigid, biocompatible and soluble or biodegradable in a body fluid. Additionally the microelectrode includes a dissolution retarding layer on the first electrode matrix element and/or a second electrode matrix element disposed between the first electrode matrix element and the electrode. Upon dissolution or biodegradation of the first electrode matrix element a drug comprised by the first electrode matrix element or the second electrode matrix element is released into the tissue. Also disclosed are bundles and arrays of the electrodes and their use.Type: ApplicationFiled: July 11, 2014Publication date: October 30, 2014Inventors: Fredrik Ek, Nils Danielsen, Jenny Eriksson Linsmeier, Per Petersson, Jens Schouenborg
-
Publication number: 20120123318Abstract: A medical microelectrode includes an elongate electrode body including a tip section, a main body section and, optionally, a coupling section. The tip section, the main body section and, optionally, the coupling section are embedded in a first electrode matrix element, which is substantially rigid, biocompatible and soluble or biodegradable in a body fluid. Additionally the microelectrode includes a dissolution retarding layer on the first electrode matrix element and/or a second electrode matrix element disposed between the first electrode matrix element and the electrode. Upon dissolution or biodegradation of the first electrode matrix element a drug comprised by the first electrode matrix element or the second electrode matrix element is released into the tissue. Also disclosed are bundles and arrays of the electrodes and their use.Type: ApplicationFiled: June 3, 2010Publication date: May 17, 2012Inventors: Fredrik Ek, Nils Danielsen, Jenny Eriksson Linsmeier, Per Petersson, Jens Schouenborg
-
Patent number: 6599517Abstract: A composition suitable for restoring bone tissue in a human or animal body, which comprises a solid, preferably particulate, calcium phosphate as a biocompatible bone tissue substitute material distributed in a lamellar liquid crystalline phase comprising at least one phospholipid and water or other aqueous liquid as a bioacceptable carrier therefor, said lamellar crystalline phase being pre-formed or being formed in situ in said body in the presence of said water or other aqueous liquid, e.g., body fluid.Type: GrantFiled: April 16, 2001Date of Patent: July 29, 2003Assignee: Camarus ABInventors: Helena Ljusberg-Wahren, Nils Danielsen